{"entity":"johnson-johnson","id":"ent_johnson-johnson","name":"Johnson & Johnson","wikidata":"Q333718","page":"https://asof.is/record/johnson-johnson","summary":"As of November 12, 2025, Johnson & Johnson was an U.S. multinational manufacturer of pharmaceuticals and medical devices, headquartered in New Brunswick and founded in 1886. Its CEO was Joaquín Duato, since 2022. It reported revenue of $88.82B for the period ended December 29, 2024.","title":"Johnson & Johnson: CEO Joaquín Duato, revenue $88.82B","key_facts":[{"label":"CEO","value":"Joaquín Duato","note":"since 2022","claim":"clm_417259548AAF"},{"label":"Chair","value":"Joaquin Duato","claim":"clm_4B621D47F882"},{"label":"Headquarters","value":"New Brunswick","claim":"clm_5D9D7F332E94"},{"label":"Founded","value":"1886","claim":"clm_7408A6454730"},{"label":"Revenue","value":"$88.82B","recorded":"88,821,000,000 United States dollar","note":"to 2024-12-29","claim":"clm_948A7BE90437"},{"label":"Ticker","value":"JNJ · NYSE","claim":"clm_AC3F2B6AB463"}],"faq":[{"question":"Who is the CEO of Johnson & Johnson?","answer":"Joaquín Duato, since 2022, as the AsOf record states with its sources."},{"question":"Where is Johnson & Johnson headquartered?","answer":"New Brunswick."},{"question":"When was Johnson & Johnson founded?","answer":"In 1886."},{"question":"What is Johnson & Johnson's revenue?","answer":"$88.82B for the period ended December 29, 2024."}],"as_of":"2025-11-12","known_by":null,"since":null,"fact_pages":[{"predicate":"ceo","page":"https://asof.is/record/johnson-johnson/ceo","md":"https://asof.is/record/johnson-johnson/ceo.md","json":"https://asof.is/v1/entities/johnson-johnson/ceo"},{"predicate":"chair","page":"https://asof.is/record/johnson-johnson/chair","md":"https://asof.is/record/johnson-johnson/chair.md","json":"https://asof.is/v1/entities/johnson-johnson/chair"},{"predicate":"board_member","page":"https://asof.is/record/johnson-johnson/board_member","md":"https://asof.is/record/johnson-johnson/board_member.md","json":"https://asof.is/v1/entities/johnson-johnson/board_member"},{"predicate":"headquarters","page":"https://asof.is/record/johnson-johnson/headquarters","md":"https://asof.is/record/johnson-johnson/headquarters.md","json":"https://asof.is/v1/entities/johnson-johnson/headquarters"},{"predicate":"founded","page":"https://asof.is/record/johnson-johnson/founded","md":"https://asof.is/record/johnson-johnson/founded.md","json":"https://asof.is/v1/entities/johnson-johnson/founded"},{"predicate":"revenue","page":"https://asof.is/record/johnson-johnson/revenue","md":"https://asof.is/record/johnson-johnson/revenue.md","json":"https://asof.is/v1/entities/johnson-johnson/revenue"},{"predicate":"net_income","page":"https://asof.is/record/johnson-johnson/net_income","md":"https://asof.is/record/johnson-johnson/net_income.md","json":"https://asof.is/v1/entities/johnson-johnson/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/johnson-johnson/operating_income","md":"https://asof.is/record/johnson-johnson/operating_income.md","json":"https://asof.is/v1/entities/johnson-johnson/operating_income"},{"predicate":"quarterly_revenue","page":"https://asof.is/record/johnson-johnson/quarterly_revenue","md":"https://asof.is/record/johnson-johnson/quarterly_revenue.md","json":"https://asof.is/v1/entities/johnson-johnson/quarterly_revenue"}],"products":[],"coverage":{"entity":"johnson-johnson","name":"Johnson & Johnson","kind":"organization","sources":[{"source":"wikidata","item":"Q333718","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":200406,"ticker":"JNJ","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":443,"open":29,"retracted":0,"first":"1886-01-01","predicates":{"cash_and_equivalents":{"claims":76,"open":1,"kind":"fact"},"quarterly_revenue":{"claims":36,"open":1,"kind":"fact"},"total_equity":{"claims":73,"open":1,"kind":"fact"},"shares_outstanding":{"claims":70,"open":1,"kind":"fact"},"total_assets":{"claims":71,"open":1,"kind":"fact"},"net_income":{"claims":16,"open":1,"kind":"fact"},"board_member":{"claims":5,"open":5,"kind":"list"},"cik":{"claims":1,"open":1,"kind":"identifier"},"quarterly_net_income":{"claims":46,"open":1,"kind":"fact"},"operating_income":{"claims":6,"open":1,"kind":"fact"},"quarterly_operating_income":{"claims":15,"open":1,"kind":"fact"},"revenue":{"claims":10,"open":1,"kind":"fact"},"x_username":{"claims":1,"open":1,"kind":"identifier"},"registrant_name":{"claims":2,"open":1,"kind":"fact"},"ceo":{"claims":1,"open":1,"kind":"fact"},"research_and_development":{"claims":5,"open":1,"kind":"fact"},"chair":{"claims":1,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"founded":{"claims":1,"open":1,"kind":"fact"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"verification","label":"a page the web verifier found (verify_claims.py)","claims":1,"last_added":"2026-11-11","last_checked":"2026-11-11","last_verified":null},{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":434,"last_added":"2026-11-08","last_checked":"2026-11-09","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":8,"last_added":"2026-11-08","last_checked":"2026-11-11","last_verified":null}],"gaps":["posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_165D1EEBD590","predicate":"board_member","value":"Darius Adamczyk","valid_from":"2022-02-15","valid_to":null,"published":"2022-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson board member: Darius Adamczyk\", as of 2022-02-15. Claim clm_165D1EEBD590, https://asof.is/claim/clm_165D1EEBD590, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000017/jnj-20220215.htm.","url":"https://asof.is/claim/clm_165D1EEBD590","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000017/jnj-20220215.htm","tier":"primary","publisher":null,"published_at":"2022-02-16T00:00:00+00:00"},{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"page-read","on":"2026-11-10","quote":"Johnson & Johnson (the “Company”) announced on February 15, 2022, that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, has been appointed to its Board of Directors (the “Board”), effective immediately.","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000017/jnj-20220215.htm"}},{"id":"clm_7A5ED01035E7","predicate":"board_member","value":"Joaquín Duato","valid_from":"2022-01-03","valid_to":null,"published":"2021-08-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson board member: Joaquín Duato\", as of 2022-01-03. Claim clm_7A5ED01035E7, https://asof.is/claim/clm_7A5ED01035E7, accessed 2026-11-12. Source: https://www.jnj.com/latest-news/learn-about-joaquin-duato-johnson-johnson-new-ceo#:~:text=In%20January%202022%2C%20Joaquin%20Duato,multiple%20countries%20around%20the%20globe..","url":"https://asof.is/claim/clm_7A5ED01035E7","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.jnj.com/latest-news/learn-about-joaquin-duato-johnson-johnson-new-ceo#:~:text=In%20January%202022%2C%20Joaquin%20Duato,multiple%20countries%20around%20the%20globe.","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm","tier":"primary","publisher":null,"published_at":"2022-01-06T00:00:00+00:00"},{"url":"https://www.cnbc.com/2021/08/19/jj-names-joaquin-duato-as-ceo-effective-january-3-replacing-alex-gorsky.html","tier":"secondary","publisher":null,"published_at":"2021-08-19T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-10","quote":"effective as of January 3, 2022, Joaquin Duato, previously Vice Chairman of the Company’s Executive Committee, assumed the role of Chief Executive Officer (“CEO”) of the Company and has been appointed as a member of the Company’s Board of Directors (the “Board”).","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm"}},{"id":"clm_15D6EEB05917","predicate":"board_member","value":"Nadja West","valid_from":"2020-12-03","valid_to":null,"published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson board member: Nadja West\", as of 2020-12-03. Claim clm_15D6EEB05917, https://asof.is/claim/clm_15D6EEB05917, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000061/jnj-20201203.htm.","url":"https://asof.is/claim/clm_15D6EEB05917","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040620000061/jnj-20201203.htm","tier":"primary","publisher":null,"published_at":"2020-12-03T00:00:00+00:00"},{"url":"https://www.jnj.com/leadership/nadja-y-west","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"page-read","on":"2026-11-11","quote":"Johnson & Johnson (the \"Company\") announced on December 3, 2020, that Dr. Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General, has been appointed to its Board of Directors (the \"Board\"), effective immediately.","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040620000061/jnj-20201203.htm"}},{"id":"clm_54109191A8F2","predicate":"board_member","value":"Hubert Joly","valid_from":"2019-12-05","valid_to":null,"published":"2019-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson board member: Hubert Joly\", as of 2019-12-05. Claim clm_54109191A8F2, https://asof.is/claim/clm_54109191A8F2, accessed 2026-11-12. Source: https://www.jnj.com/leadership/hubert-joly.","url":"https://asof.is/claim/clm_54109191A8F2","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.jnj.com/leadership/hubert-joly","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040619000069/a20191205form8-k.htm","tier":"primary","publisher":null,"published_at":"2019-12-05T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-10","quote":"Johnson & Johnson (the \"Company\") announced on December 5, 2019, that Hubert Joly, Executive Chairman of Best Buy Co., Inc., and Mark A. Weinberger, former EY Global Chairman and CEO, have been appointed to its Board of Directors (the \"Board\"), effective immediately.","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040619000069/a20191205form8-k.htm"}},{"id":"clm_09A8C2E45663","predicate":"board_member","value":"Mary Beckerle","valid_from":"2015-06-09","valid_to":null,"published":"2015-06-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson board member: Mary Beckerle\", as of 2015-06-09. Claim clm_09A8C2E45663, https://asof.is/claim/clm_09A8C2E45663, accessed 2026-11-12. Source: https://www.jnj.com/leadership/mary-c-beckerle.","url":"https://asof.is/claim/clm_09A8C2E45663","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.jnj.com/leadership/mary-c-beckerle","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000028/a20150609form8-kbeckerle.htm","tier":"primary","publisher":null,"published_at":"2015-06-09T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-10","quote":"The company announced on June 9, 2015 that its Board of Directors has appointed Mary Beckerle, Ph.D., Chief Executive Officer and Director of Huntsman Cancer Institute at the University of Utah, as a Director of Johnson & Johnson.","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000028/a20150609form8-kbeckerle.htm"}},{"id":"clm_A4F230EF9BBB","predicate":"cash_and_equivalents","value":"18,231,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,231,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_A4F230EF9BBB, https://asof.is/claim/clm_A4F230EF9BBB, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_A4F230EF9BBB","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9D46DE0A4F23","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_417259548AAF","predicate":"ceo","value":"Joaquín Duato","valid_from":"2022-01-03","valid_to":null,"published":"2021-08-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson ceo: Joaquín Duato\", as of 2022-01-03. Claim clm_417259548AAF, https://asof.is/claim/clm_417259548AAF, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm.","url":"https://asof.is/claim/clm_417259548AAF","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm","tier":"primary","publisher":null,"published_at":"2022-01-06T00:00:00+00:00"},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040621000061/exhibit99.htm","tier":"primary","publisher":null,"published_at":"2021-08-20T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"effective as of January 3, 2022, Joaquin Duato, previously Vice Chairman of the Company’s Executive Committee, assumed the role of Chief Executive Officer (“CEO”) of the Company","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm"}},{"id":"clm_4B621D47F882","predicate":"chair","value":"Joaquin Duato","valid_from":"2023-01-01","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson chair: Joaquin Duato\", as of 2023-01-01. Claim clm_4B621D47F882, https://asof.is/claim/clm_4B621D47F882, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm.","url":"https://asof.is/claim/clm_4B621D47F882","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm","tier":"primary","publisher":null,"published_at":"2026-02-11T00:00:00+00:00"},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000063/jnj-20260309.htm","tier":"primary","publisher":"SEC EDGAR DEF 14A","published_at":"2026-03-11T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"Joaquin Duato, 63 Chairman of the Board; Chief Executive Officer Mr. J. Duato became Chairman of the Board of Directors in 2023 subsequent to his appointments as Chief Executive Officer and Director in 2022.","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm"}},{"id":"clm_0AE18A6EB213","predicate":"cik","value":"0000200406","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cik: 0000200406\", undated. Claim clm_0AE18A6EB213, https://asof.is/claim/clm_0AE18A6EB213, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_0AE18A6EB213","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_5254AF4AFDB0","predicate":"fiscal_year_end","value":"01-03","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson fiscal year end: 01-03\", undated. Claim clm_5254AF4AFDB0, https://asof.is/claim/clm_5254AF4AFDB0, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5254AF4AFDB0","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_7408A6454730","predicate":"founded","value":"1886","valid_from":"1886-01-01","valid_to":null,"published":null,"recorded":"2026-11-11","citation":{"plain":"AsOf. \"Johnson & Johnson founded: 1886\", as of 1886-01-01. Claim clm_7408A6454730, https://asof.is/claim/clm_7408A6454730, accessed 2026-11-12. Source: https://www.jnj.com/our-heritage/meet-the-innovative-brothers-who-founded-johnson-johnson-in-1886.","url":"https://asof.is/claim/clm_7408A6454730","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.jnj.com/our-heritage/meet-the-innovative-brothers-who-founded-johnson-johnson-in-1886","tier":"primary","publisher":"jnj.com","published_at":null}],"evidence":{"by":"page-read","on":"2026-11-11","quote":"They were brothers Robert, James and Edward Mead Johnson, and in 1886, they brought together their respective talents to found a small family company that bore their surname.","url":"https://www.jnj.com/our-heritage/meet-the-innovative-brothers-who-founded-johnson-johnson-in-1886"}},{"id":"clm_5D9D7F332E94","predicate":"headquarters","value":"New Brunswick","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson headquarters: New Brunswick\", undated. Claim clm_5D9D7F332E94, https://asof.is/claim/clm_5D9D7F332E94, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5D9D7F332E94","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null},{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.med-dept.com/resources/ww2-medical-equipment-manufacturers-and-suppliers/","tier":"secondary","publisher":null,"published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_BCF468D9A07B","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson listed on: NYSE\", undated. Claim clm_BCF468D9A07B, https://asof.is/claim/clm_BCF468D9A07B, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_BCF468D9A07B","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_62CFC14840C5","predicate":"net_income","value":"14,066,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 14,066,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_62CFC14840C5, https://asof.is/claim/clm_62CFC14840C5, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_62CFC14840C5","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_04E6B87CA267","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-13"}},{"id":"clm_BAB563999E2E","predicate":"operating_income","value":"21,590,000,000 United States dollar","valid_from":"2014-12-28","valid_to":null,"published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 21,590,000,000 United States dollar\", as of 2014-12-28. Claim clm_BAB563999E2E, https://asof.is/claim/clm_BAB563999E2E, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_BAB563999E2E","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-24"}},{"id":"clm_4AB4EF856D4C","predicate":"quarterly_net_income","value":"5,152,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,152,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_4AB4EF856D4C, https://asof.is/claim/clm_4AB4EF856D4C, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_4AB4EF856D4C","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_636E850C3608","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_B42FC6E71EE6","predicate":"quarterly_operating_income","value":"5,827,000,000 United States dollar","valid_from":"2015-03-29","valid_to":null,"published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,827,000,000 United States dollar\", as of 2015-03-29. Claim clm_B42FC6E71EE6, https://asof.is/claim/clm_B42FC6E71EE6, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_B42FC6E71EE6","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_729D980FE153","predicate":"quarterly_revenue","value":"23,993,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,993,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_729D980FE153, https://asof.is/claim/clm_729D980FE153, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_729D980FE153","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D62C3B5C845","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_3F2BC974D10A","predicate":"registrant_name","value":"JOHNSON & JOHNSON","valid_from":"1996-01-23","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson registrant name: JOHNSON & JOHNSON\", as of 1996-01-23. Claim clm_3F2BC974D10A, https://asof.is/claim/clm_3F2BC974D10A, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_3F2BC974D10A","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_447FFAF7D0DA","predicate":"research_and_development","value":"1,841,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 1,841,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_447FFAF7D0DA, https://asof.is/claim/clm_447FFAF7D0DA, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_447FFAF7D0DA","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_845673D0E6C8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-13"}},{"id":"clm_948A7BE90437","predicate":"revenue","value":"88,821,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 88,821,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_948A7BE90437, https://asof.is/claim/clm_948A7BE90437, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_948A7BE90437","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_249E6427F083","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2024, filed 2025-02-13"}},{"id":"clm_D97FEC131483","predicate":"shares_outstanding","value":"2,409,295,102 shares","valid_from":"2025-10-17","valid_to":"2026-02-06","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,409,295,102 shares\", as of 2025-10-17 (until 2026-02-06). Claim clm_D97FEC131483, https://asof.is/claim/clm_D97FEC131483, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_D97FEC131483","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD98E84FA8C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_94332C756B27","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_94332C756B27, https://asof.is/claim/clm_94332C756B27, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_94332C756B27","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_CF21B28C04B0","predicate":"state_of_incorporation","value":"NJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson state of incorporation: NJ\", undated. Claim clm_CF21B28C04B0, https://asof.is/claim/clm_CF21B28C04B0, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_CF21B28C04B0","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_AC3F2B6AB463","predicate":"ticker","value":"JNJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson ticker: JNJ\", undated. Claim clm_AC3F2B6AB463, https://asof.is/claim/clm_AC3F2B6AB463, accessed 2026-11-12. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_AC3F2B6AB463","accessed":"2026-11-12"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_7E3589121DB9","predicate":"total_assets","value":"192,816,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 192,816,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_7E3589121DB9, https://asof.is/claim/clm_7E3589121DB9, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_7E3589121DB9","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AFEC68E6D52E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_63969A827BEB","predicate":"total_equity","value":"79,277,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 79,277,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_63969A827BEB, https://asof.is/claim/clm_63969A827BEB, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_63969A827BEB","accessed":"2026-11-12"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BDE73F201969","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_E1C3F58B38A0","predicate":"website","value":"https://www.jnj.com","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson website: https://www.jnj.com\", undated. Claim clm_E1C3F58B38A0, https://asof.is/claim/clm_E1C3F58B38A0, accessed 2026-11-12. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_E1C3F58B38A0","accessed":"2026-11-12"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-11","quote":"Johnson & Johnson: Changing health for humanity.","url":"https://www.jnj.com"}},{"id":"clm_3B23008B4919","predicate":"x_username","value":"JNJNews","valid_from":"2009-02-09","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson x username: JNJNews\", as of 2009-02-09. Claim clm_3B23008B4919, https://asof.is/claim/clm_3B23008B4919, accessed 2026-11-12. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_3B23008B4919","accessed":"2026-11-12"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/JNJNews","url":"https://www.jnj.com"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"page-read":"its source page states the value and the date","sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}